ReadYourDNA

rs10096633 (LPL)

What you carry at this position in your DNA and what research says about it.

Triglycerides and Heart Health: 10/10 evidence, 27 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): C/C

Higher Triglycerides and Elevated Diabetes Risk

Having two copies of the C allele is associated with less efficient clearance of fats from your blood. This leads to higher circulating triglycerides, lower HDL cholesterol, and a slightly increased risk of type 2 diabetes.

What this genotype means: Higher circulating triglycerides; Lower HDL cholesterol; Slightly higher risk of type 2 diabetes.

Sample genotype (not yours): C/T

Typical Lipid Profile and Diabetes Risk

Carrying one copy of the T allele provides a moderate benefit, helping to keep your triglyceride and cholesterol levels within a typical range. Your genetic risk for type 2 diabetes is also average.

What this genotype means: Typical triglyceride levels; Typical HDL cholesterol levels; Average risk of type 2 diabetes.

Sample genotype (not yours): T/T

Optimal Lipid Profile and Lower Diabetes Risk

Carrying two copies of the T allele is associated with highly efficient fat clearance from the bloodstream. This results in lower triglycerides, higher HDL cholesterol, and a reduced risk of type 2 diabetes.

What this genotype means: Lower circulating triglycerides; Higher HDL cholesterol; Reduced risk of type 2 diabetes.

About LPL

Gene function and biological role

Gene Function: Encoding the lipoprotein lipase enzyme, the LPL gene is essential for lipid metabolism [1]. This enzyme plays a critical role by hydrolyzing triglycerides carried in chylomicrons and very-low-density lipoproteins into free fatty acids [2]. These released fatty acids are then utilized by surrounding tissues for energy production or stored as fat [1]. By breaking down these triglyceride-rich particles, lipoprotein lipase also facilitates the maturation and elevation of high-density lipoprotein (HDL) cholesterol [3]. Consequently, genetic variations that alter LPL expression or activity can significantly impact circulating lipid profiles and cardiovascular risk [4].

Variant Impact: Located on chromosome 8 near the LPL gene, rs10096633 is an intergenic genetic marker [1]. This single nucleotide polymorphism is in strong linkage disequilibrium with functional variants in the LPL gene, meaning it serves as a highly reliable proxy for LPL enzyme efficiency [4]. The C allele is associated with higher levels of circulating triglycerides and lower levels of HDL cholesterol [2]. Conversely, the T allele is linked to more efficient triglyceride clearance and higher HDL cholesterol levels [3]. Because of its strong influence on lipid clearance, this variant is also associated with downstream metabolic outcomes, including the risk of developing type 2 diabetes [5].

Key Insight: This variant acts as a genetic proxy for lipoprotein lipase efficiency, directly influencing how quickly your body clears dietary fats from the bloodstream. Carrying the protective T allele not only lowers triglycerides but also naturally boosts HDL cholesterol and reduces type 2 diabetes risk.

Location: LPL. Chromosome 8 · 8p21.3 · 20.0 Mb

Genotype Frequencies

Estimated prevalence by population

Global 64.2%; European 76.2%; African 33.1%; East Asian 79.6%; South Asian 79.2%; Americas 74.0%; Ashkenazi 63.6%; Finnish 80.7%; Middle Eastern 67.7%; Amish 63.2%.

Estimated CC genotype frequency.

Global 29.6%; European 22.2%; African 48.9%; East Asian 19.3%; South Asian 19.6%; Americas 24.1%; Ashkenazi 32.3%; Finnish 18.3%; Middle Eastern 29.1%; Amish 32.6%.

Estimated CT genotype frequency.

Global 6.2%; European 1.6%; African 18.1%; East Asian 1.2%; South Asian 1.2%; Americas 2.0%; Ashkenazi 4.1%; Finnish 1.0%; Middle Eastern 3.1%; Amish 4.2%.

Estimated TT genotype frequency.

Associated Traits

Showing effects for C/C genotype

Cardiovascular & Metabolic

Lipids & Cholesterol

Triglycerides. Evidence: 10/10. Source: PMID 19060911. Higher Levels.

HDL Cholesterol. Evidence: 10/10. Source: PMID 21347282. Lower Levels.

LDL Cholesterol. Evidence: 9/10. Source: PMID 35213538. Higher Levels.

Diabetes & Glycemic Traits

Type 2 Diabetes. Evidence: 7/10. Source: PMID 30297969. Slightly Higher Risk.

Showing effects for C/T genotype

Triglycerides. Evidence: 10/10. Source: PMID 19060911. Typical Levels.

HDL Cholesterol. Evidence: 10/10. Source: PMID 21347282. Typical Levels.

LDL Cholesterol. Evidence: 9/10. Source: PMID 35213538. Typical Levels.

Type 2 Diabetes. Evidence: 7/10. Source: PMID 30297969. Typical Risk.

Showing effects for T/T genotype

Triglycerides. Evidence: 10/10. Source: PMID 19060911. Lower Levels.

HDL Cholesterol. Evidence: 10/10. Source: PMID 21347282. Higher Levels.

LDL Cholesterol. Evidence: 9/10. Source: PMID 35213538. Lower Levels.

Type 2 Diabetes. Evidence: 7/10. Source: PMID 30297969. Slightly Lower Risk.

What CC Genotype Means

What this genotype means for the people who carry it

Sample genotype: CC (Homozygous)

A genetic profile with two copies of the C allele is the most common globally. Large-scale genome-wide association studies have consistently linked this profile to less efficient lipoprotein lipase activity [1]. As a result, individuals with this genotype tend to have higher circulating levels of triglycerides and lower levels of protective HDL cholesterol [2]. These lipid imbalances can contribute to a higher risk of cardiovascular issues over time [3]. Additionally, this genetic profile is associated with a slightly elevated risk of developing type 2 diabetes [4]. Maintaining a healthy diet low in simple sugars and engaging in regular physical activity are particularly beneficial strategies for managing lipid levels with this genetic background [5].

Higher circulating triglycerides; Lower HDL cholesterol; Slightly higher risk of type 2 diabetes.

What CT Genotype Means

Sample genotype: CT (Heterozygous)

An intermediate genetic profile with one C allele and one T allele represents a balanced state. Research indicates that individuals with this profile generally exhibit intermediate lipoprotein lipase activity [1]. Consequently, circulating levels of triglycerides and HDL cholesterol tend to fall within the typical population average [2]. This intermediate activity also translates to a standard, baseline risk for cardiovascular conditions and type 2 diabetes [3]. While you do not have the maximum lipid-lowering benefits of the double-T genotype, you are partially protected against the higher lipid levels seen in C/C homozygotes [4]. Standard lifestyle recommendations, including a balanced diet and regular exercise, remain highly effective for maintaining optimal metabolic health [5].

Typical triglyceride levels; Typical HDL cholesterol levels; Average risk of type 2 diabetes.

What TT Genotype Means

Sample genotype: TT (Homozygous)

A double-T genetic profile is the least common globally but offers significant metabolic advantages. Having two copies of the T allele is strongly associated with highly efficient lipoprotein lipase enzyme activity [1]. This enhanced efficiency allows your body to clear dietary triglycerides from the bloodstream rapidly, resulting in lower circulating triglyceride levels [2]. Furthermore, this process naturally boosts high-density lipoprotein (HDL) cholesterol, which helps protect blood vessels [3]. Studies have also demonstrated that this genetic profile is associated with a reduced risk of developing type 2 diabetes [4]. Regular physical activity has been shown to synergize exceptionally well with this genotype, further enhancing cardiovascular protection [5].

Lower circulating triglycerides; Higher HDL cholesterol; Reduced risk of type 2 diabetes.

Related Variants

Variants with shared genetic architecture

rs115849089 · LPL Gene · Chr 8 · Triglyceride Levels

rs12678919 · LPL Gene · Chr 8 · Cholesterol and Lipids

rs13702 · LPL Gene · Chr 8 · Blood Triglyceride Levels

Sources

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.

Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.

Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.

Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.

Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com